Cargando…

lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis

Long non‐coding RNAs (lncRNAs) take various biological effects in clear cell renal cell carcinoma (ccRCC) mostly through sponging with microRNAs (miRNAs). lncRNA MIR4435‐2HG is found to promote tumour progression in gastric cancer, glioblastoma and hepatocellular carcinoma. However, the role of lncR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Kai, Miao, Chenkui, Tian, Ye, Qin, Zhiqiang, Xue, Jianxin, Xia, Jiadong, Zhu, Shenhao, Xu, Aiming, Yang, Jie, Wang, Zengjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520272/
https://www.ncbi.nlm.nih.gov/pubmed/33460239
http://dx.doi.org/10.1111/jcmm.15609
_version_ 1783587750568525824
author Zhu, Kai
Miao, Chenkui
Tian, Ye
Qin, Zhiqiang
Xue, Jianxin
Xia, Jiadong
Zhu, Shenhao
Xu, Aiming
Yang, Jie
Wang, Zengjun
author_facet Zhu, Kai
Miao, Chenkui
Tian, Ye
Qin, Zhiqiang
Xue, Jianxin
Xia, Jiadong
Zhu, Shenhao
Xu, Aiming
Yang, Jie
Wang, Zengjun
author_sort Zhu, Kai
collection PubMed
description Long non‐coding RNAs (lncRNAs) take various biological effects in clear cell renal cell carcinoma (ccRCC) mostly through sponging with microRNAs (miRNAs). lncRNA MIR4435‐2HG is found to promote tumour progression in gastric cancer, glioblastoma and hepatocellular carcinoma. However, the role of lncRNA MIR4435‐2HG in ccRCC progression remains unknown. The purpose of this research was to investigate the potential molecular mechanism of lncRNA MIR4435‐2HG regarding the regulation of ccRCC initiation and progression. In this study, we found the up‐regulation of MIR4435‐2HG in ccRCC tissues and cell lines. Functionally, overexpression of MIR4435‐2HG promoted the proliferation as well as the metastasis in ccRCC cell lines, whereas knockdown of MIR4435‐2HG inhibited the above changes. Then, bioinformatic analysis and luciferase reporter assays confirmed the negative regulation effect of MIR4435‐2HG on miR‐513a‐5p. And further investigations showed that KLF6, which collected from the intersection of databases, was the potential conjugated mRNAs of miR‐513a‐5p. Finally, the rescue experiments revealed the relation among MIR4435‐2HG and KLF6, which showed that KLF6 could reverse the promoting effect of MIR4435‐2HG on ccRCC in vitro and in vivo. Therefore, our findings provided insight into the mechanisms of MIR4435‐2HG in ccRCC and revealed an alternative target for the clinical diagnosis and treatment of ccRCC.
format Online
Article
Text
id pubmed-7520272
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75202722020-09-30 lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis Zhu, Kai Miao, Chenkui Tian, Ye Qin, Zhiqiang Xue, Jianxin Xia, Jiadong Zhu, Shenhao Xu, Aiming Yang, Jie Wang, Zengjun J Cell Mol Med Original Articles Long non‐coding RNAs (lncRNAs) take various biological effects in clear cell renal cell carcinoma (ccRCC) mostly through sponging with microRNAs (miRNAs). lncRNA MIR4435‐2HG is found to promote tumour progression in gastric cancer, glioblastoma and hepatocellular carcinoma. However, the role of lncRNA MIR4435‐2HG in ccRCC progression remains unknown. The purpose of this research was to investigate the potential molecular mechanism of lncRNA MIR4435‐2HG regarding the regulation of ccRCC initiation and progression. In this study, we found the up‐regulation of MIR4435‐2HG in ccRCC tissues and cell lines. Functionally, overexpression of MIR4435‐2HG promoted the proliferation as well as the metastasis in ccRCC cell lines, whereas knockdown of MIR4435‐2HG inhibited the above changes. Then, bioinformatic analysis and luciferase reporter assays confirmed the negative regulation effect of MIR4435‐2HG on miR‐513a‐5p. And further investigations showed that KLF6, which collected from the intersection of databases, was the potential conjugated mRNAs of miR‐513a‐5p. Finally, the rescue experiments revealed the relation among MIR4435‐2HG and KLF6, which showed that KLF6 could reverse the promoting effect of MIR4435‐2HG on ccRCC in vitro and in vivo. Therefore, our findings provided insight into the mechanisms of MIR4435‐2HG in ccRCC and revealed an alternative target for the clinical diagnosis and treatment of ccRCC. John Wiley and Sons Inc. 2020-07-30 2020-09 /pmc/articles/PMC7520272/ /pubmed/33460239 http://dx.doi.org/10.1111/jcmm.15609 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhu, Kai
Miao, Chenkui
Tian, Ye
Qin, Zhiqiang
Xue, Jianxin
Xia, Jiadong
Zhu, Shenhao
Xu, Aiming
Yang, Jie
Wang, Zengjun
lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
title lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
title_full lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
title_fullStr lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
title_full_unstemmed lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
title_short lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
title_sort lncrna mir4435‐2hg promoted clear cell renal cell carcinoma malignant progression via mir‐513a‐5p/klf6 axis
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520272/
https://www.ncbi.nlm.nih.gov/pubmed/33460239
http://dx.doi.org/10.1111/jcmm.15609
work_keys_str_mv AT zhukai lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT miaochenkui lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT tianye lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT qinzhiqiang lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT xuejianxin lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT xiajiadong lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT zhushenhao lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT xuaiming lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT yangjie lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis
AT wangzengjun lncrnamir44352hgpromotedclearcellrenalcellcarcinomamalignantprogressionviamir513a5pklf6axis